Provexis Plc PXS.L

0.9500‎p‎0(0%)(1D)

• Delayed prices by LSE PLC • in GBX

Invest in Provexis Plc
Today

Create an eToro account to buy PXS.L stock on a secure, user-friendly, multi-asset trading platform.

Provexis Plc PXS.L

Buy PXS.L

Trending stocks

See stocks with the biggest daily volume spikes vs. their 3-month average.

CNTA

Centessa Pharmaceuticals plc

‎$‎39.72

+44.02%

APLS

Apellis Pharmaceuticals Inc.

Exela Technologies Pref

‎$‎0

+1,500.00%

ELPC

Companhia Paranaense de Energia - COPEL

MAX

*Past performance is not an indication of future results

Jump to:

About PXS.L >
How to Buy? >
Top Guides >

The Provexis Plc share price is stable this week.

The Provexis Plc share price today is 0.9500‎p‎, reflecting a ‎0‎% change over the last 24 hours and ‎0‎% over the past week. The current market capitalization of PXS.L is 14.13M‎p‎ with an average volume in the last three months of 662705.9. The stock has a P/E ratio of -30.12 and a dividend yield of 0%. With the stock’s beta sitting at 0.1

Why invest in stocks on eToro?

Start with ‎$‎50

Low fees

users worldwide

Across 70+ countries

Get Started

PXS.L Key Metrics

Market Cap

14.13M‎p‎

Day’s Range

0.95‎p‎ - 0.95‎p‎

52W Range

0.3994‎p‎ - 1.4977‎p‎

Average Volume (3M)

662705.9

Price-Earnings Ratio

-30.12

Revenue

1.2M‎p‎

Dividend (Yield)

0‎p‎ (0%)

Prev Close

0.95‎p‎

EPS

0‎p‎

Beta

0.1

How can I buy Provexis Plc stocks?

To purchase Provexis Plc:

Create an eToro account:

Deposit funds:

Deposit funds into your eToro account using your preferred payment method.

Search and purchase:

Search the Provexis Plc (PXS.L) page and place an order to buy Provexis Plc.

Buy PXS.L

Looking for more information? Check out our guide on Academy.

What Is Provexis Plc?

Provexis Plc is a life-science business engaged in the research, development, and licensing of health supplements and nutritional products. The firm, which is based in the United Kingdom, conducts operations internationally.

As a part of the healthcare sector, specifically under biotechnology and medical research, Provexis develops pioneering biomedical technology. This includes the firm’s signature product, Fruitflow, an antithrombotic supplement that contributes to healthy blood flow and heart health.

Diversify your virtual portfolio by adding PXS.L shares to your eToro watchlist.

CEO

Ian Ford

Employees

Founded

1999

Reading, Berkshire, GB

Med Tech

LSE AIM

Get Started

Top Guides

Our top picks for the most relevant guides from the eToro Academy

Top Dividend Stocks for 2026

Gear up for 2026 with top dividend stocks. Explore the potential of J&J, Chevron, Coca Cola, Verizon, Caterpillar, McDonald’s with eToro’s expert analysts.

Stock Trading And Investing For Beginners

Learn stock trading basics with our beginner's guide. Discover how to choose stocks, manage risks, and build your first investment portfolio.

AI Stocks Poised for Growth in 2026

Gear up for 2026 with AI stocks. Dive into the potential of Nvidia, Broadcom, CrowdStrike, Arista Networks, and Amphenol, through eToro’s expert analysis.

Go to the Academy >

Invest in Provexis Plc
Today

Create an eToro account to buy PXS.L stock on a secure, user-friendly, multi-asset trading platform.

Get Started

FAQ

What is the current price of Provexis Plc stock?

The current price of PXS.L is 0.9500‎p‎.

What are analysts’ forecasts for Provexis Plc?

Analysts offer forecasts for Provexis Plc based on market trends, financial reports and projected growth. Check the latest forecast for future price movements.

What is the market cap of Provexis Plc?

The market capitalisation of Provexis Plc is 14.13M‎p‎

Daily Movers

Explore the biggest stocks movers on the market.